过氧化氢(H_(2)O_(2))是一种重要的化工产品,广泛应用于污水处理、消毒杀菌和印染漂白等领域.在蒽醌法生产H_(2)O_(2)的过程中,易产生有毒气体并存在爆炸危险.因此,仅利用水、氧气和太阳光即可在合适的光催化剂上生成H_(2)O_(2)的光催...过氧化氢(H_(2)O_(2))是一种重要的化工产品,广泛应用于污水处理、消毒杀菌和印染漂白等领域.在蒽醌法生产H_(2)O_(2)的过程中,易产生有毒气体并存在爆炸危险.因此,仅利用水、氧气和太阳光即可在合适的光催化剂上生成H_(2)O_(2)的光催化技术备受关注.本课题组报道了通过酸碱自组装法制备的四(4-羧基苯基)卟啉(SA-TCPP)光催化剂,用于生产H_(2)O_(2).该催化剂克服了大部分H_(2)O_(2)光催化剂存在的需要牺牲剂、活性低和光利用率不足等问题,但其性能仍受限于较高的复合率.晶面调控已被证实是改善许多无机催化剂电荷复合的有效策略,然而,对于有机光催化剂,关于暴露晶面与其活性关系的研究仍然较少.本文采用溶解-重结晶法在水和三种有机溶剂的混合物中成功合成了三种具有不同暴露晶面的卟啉光催化剂.即利用卟啉在有机溶剂和水中的溶解度差异,将卟啉先溶解在四氢呋喃(THF)、甲醇(MeOH)或乙二醇(EG)溶液中,随后在水溶液中重新结晶.X射线衍射、高分辨率透射电子显微镜及晶面模拟模型图的结果表明,三种催化剂具有相同的晶体结构,但分别暴露了(400)、(022)和(020)晶面.通过紫外分光光度计测量这些催化剂在氙灯(λ≥420 nm)照射下的光催化活性,结果表明,具有(400)暴露面的卟啉光催化剂的H_(2)O_(2)生产速率最高,可达29.33 mmol L h^(-1)g^(-1),分别是具有(022)暴露面和(020)暴露面的卟啉光催化剂的2.7倍和4.1倍,约是已报道的SA-TCPP光催化剂的1.3倍.通过紫外漫反射、莫特肖特基曲线分析以及LED灯照射下的光催化活性测试,排除了光吸收能力对这三种卟啉光催化剂活性的影响.开尔文探针力显微镜、光生电流密度谱图、晶面模拟模型图和密度泛函理论计算结果表明,活性的差异主要归因于(400)表面暴露的高羧基含量所引发的强内建电场,并且在该暴露面上的内建电场方向有利于空穴从吡咯氮向羧基碳的跃迁,因此阻碍了电荷的快速重组,促进了富有挑战性的水氧化过程,而(020)面由于暴露了最多的吡咯氮和最少的羧基碳,其产生的内建电场强度最弱,且内建电场方向阻碍了空穴向羧基碳的跃迁,因此H_(2)O_(2)生产速率最低.综上所述,本工作通过晶面调控产生强内建电场以加速空穴的迁移,降低了电子空穴复合速率,实现了高H_(2)O_(2)生产速率,为更高效的有机光催化剂的设计和开发提供了新思路.展开更多
AIM: To investigate the diagnostic validity and therapeutic value of lumbar facet joint interventions in managing chronic low back pain.METHODS: The review process applied systematic evidence-based assessment methodol...AIM: To investigate the diagnostic validity and therapeutic value of lumbar facet joint interventions in managing chronic low back pain.METHODS: The review process applied systematic evidence-based assessment methodology of controlled trials of diagnostic validity and randomized controlled trials of therapeutic efficacy. Inclusion criteria encompassed all facet joint interventions performed in a controlled fashion. The pain relief of greater than 50% was the outcome measure for diagnostic accuracy assessment of the controlled studies with ability to perform previously painful movements, whereas, for randomized controlled therapeutic efficacy studies, the primary outcome was significant pain relief and the secondary outcome was a positive change in functional status. For the inclusion of the diagnostic controlled studies, all studies must have utilized either placebo controlled facet joint blocks or comparative local anesthetic blocks. In assessing therapeutic interventions, short-term and long-term reliefs were defined as either up to 6 mo or greater than 6 mo of relief. The literature search was extensive utilizing various types of electronic search media including Pub Med from 1966 onwards, Cochrane library, National Guideline Clearinghouse, clinicaltrials.gov, along with other sources includingprevious systematic reviews, non-indexed journals, and abstracts until March 2015. Each manuscript included in the assessment was assessed for methodologic quality or risk of bias assessment utilizing the Quality Appraisal of Reliability Studies checklist for diagnostic interventions, and Cochrane review criteria and the Interventional Pain Management Techniques- Quality Appraisal of Reliability and Risk of Bias Assessment tool for therapeutic interventions. Evidence based on the review of the systematic assessment of controlled studies was graded utilizing a modified schema of qualitative evidence with best evidence synthesis, variable from level Ⅰ to level Ⅴ.RESULTS: Across all databases, 16 high quality diagnostic accuracy studies were identified. In addition, multiple studies assessed the influence of multiple factors on diagnostic validity. In contrast to diagnostic validity studies, therapeutic efficacy trials were limited to a total of 14 randomized controlled trials, assessing the efficacy of intraarticular injections, facet or zygapophysial joint nerve blocks, and radiofrequency neurotomy of the innervation of the facet joints. The evidence for the diagnostic validity of lumbar facet joint nerve blocks with at least 75% pain relief with ability to perform previously painful movements was level Ⅰ, based on a range of level Ⅰ to Ⅴ derived from a best evidence synthesis. For therapeutic interventions, the evidence was variable from level Ⅱ to Ⅲ, with level Ⅱ evidence for lumbar facet joint nerve blocks and radiofrequency neurotomy for long-term improvement(greater than 6 mo), and level Ⅲ evidence for lumbosacral zygapophysial joint injections for short-term improvement only.CONCLUSION: This review provides significant evidence for the diagnostic validity of facet joint nerve blocks, and moderate evidence for therapeutic radiofrequency neurotomy and therapeutic facet joint nerve blocks in managing chronic low back pain.展开更多
文摘过氧化氢(H_(2)O_(2))是一种重要的化工产品,广泛应用于污水处理、消毒杀菌和印染漂白等领域.在蒽醌法生产H_(2)O_(2)的过程中,易产生有毒气体并存在爆炸危险.因此,仅利用水、氧气和太阳光即可在合适的光催化剂上生成H_(2)O_(2)的光催化技术备受关注.本课题组报道了通过酸碱自组装法制备的四(4-羧基苯基)卟啉(SA-TCPP)光催化剂,用于生产H_(2)O_(2).该催化剂克服了大部分H_(2)O_(2)光催化剂存在的需要牺牲剂、活性低和光利用率不足等问题,但其性能仍受限于较高的复合率.晶面调控已被证实是改善许多无机催化剂电荷复合的有效策略,然而,对于有机光催化剂,关于暴露晶面与其活性关系的研究仍然较少.本文采用溶解-重结晶法在水和三种有机溶剂的混合物中成功合成了三种具有不同暴露晶面的卟啉光催化剂.即利用卟啉在有机溶剂和水中的溶解度差异,将卟啉先溶解在四氢呋喃(THF)、甲醇(MeOH)或乙二醇(EG)溶液中,随后在水溶液中重新结晶.X射线衍射、高分辨率透射电子显微镜及晶面模拟模型图的结果表明,三种催化剂具有相同的晶体结构,但分别暴露了(400)、(022)和(020)晶面.通过紫外分光光度计测量这些催化剂在氙灯(λ≥420 nm)照射下的光催化活性,结果表明,具有(400)暴露面的卟啉光催化剂的H_(2)O_(2)生产速率最高,可达29.33 mmol L h^(-1)g^(-1),分别是具有(022)暴露面和(020)暴露面的卟啉光催化剂的2.7倍和4.1倍,约是已报道的SA-TCPP光催化剂的1.3倍.通过紫外漫反射、莫特肖特基曲线分析以及LED灯照射下的光催化活性测试,排除了光吸收能力对这三种卟啉光催化剂活性的影响.开尔文探针力显微镜、光生电流密度谱图、晶面模拟模型图和密度泛函理论计算结果表明,活性的差异主要归因于(400)表面暴露的高羧基含量所引发的强内建电场,并且在该暴露面上的内建电场方向有利于空穴从吡咯氮向羧基碳的跃迁,因此阻碍了电荷的快速重组,促进了富有挑战性的水氧化过程,而(020)面由于暴露了最多的吡咯氮和最少的羧基碳,其产生的内建电场强度最弱,且内建电场方向阻碍了空穴向羧基碳的跃迁,因此H_(2)O_(2)生产速率最低.综上所述,本工作通过晶面调控产生强内建电场以加速空穴的迁移,降低了电子空穴复合速率,实现了高H_(2)O_(2)生产速率,为更高效的有机光催化剂的设计和开发提供了新思路.
文摘AIM: To investigate the diagnostic validity and therapeutic value of lumbar facet joint interventions in managing chronic low back pain.METHODS: The review process applied systematic evidence-based assessment methodology of controlled trials of diagnostic validity and randomized controlled trials of therapeutic efficacy. Inclusion criteria encompassed all facet joint interventions performed in a controlled fashion. The pain relief of greater than 50% was the outcome measure for diagnostic accuracy assessment of the controlled studies with ability to perform previously painful movements, whereas, for randomized controlled therapeutic efficacy studies, the primary outcome was significant pain relief and the secondary outcome was a positive change in functional status. For the inclusion of the diagnostic controlled studies, all studies must have utilized either placebo controlled facet joint blocks or comparative local anesthetic blocks. In assessing therapeutic interventions, short-term and long-term reliefs were defined as either up to 6 mo or greater than 6 mo of relief. The literature search was extensive utilizing various types of electronic search media including Pub Med from 1966 onwards, Cochrane library, National Guideline Clearinghouse, clinicaltrials.gov, along with other sources includingprevious systematic reviews, non-indexed journals, and abstracts until March 2015. Each manuscript included in the assessment was assessed for methodologic quality or risk of bias assessment utilizing the Quality Appraisal of Reliability Studies checklist for diagnostic interventions, and Cochrane review criteria and the Interventional Pain Management Techniques- Quality Appraisal of Reliability and Risk of Bias Assessment tool for therapeutic interventions. Evidence based on the review of the systematic assessment of controlled studies was graded utilizing a modified schema of qualitative evidence with best evidence synthesis, variable from level Ⅰ to level Ⅴ.RESULTS: Across all databases, 16 high quality diagnostic accuracy studies were identified. In addition, multiple studies assessed the influence of multiple factors on diagnostic validity. In contrast to diagnostic validity studies, therapeutic efficacy trials were limited to a total of 14 randomized controlled trials, assessing the efficacy of intraarticular injections, facet or zygapophysial joint nerve blocks, and radiofrequency neurotomy of the innervation of the facet joints. The evidence for the diagnostic validity of lumbar facet joint nerve blocks with at least 75% pain relief with ability to perform previously painful movements was level Ⅰ, based on a range of level Ⅰ to Ⅴ derived from a best evidence synthesis. For therapeutic interventions, the evidence was variable from level Ⅱ to Ⅲ, with level Ⅱ evidence for lumbar facet joint nerve blocks and radiofrequency neurotomy for long-term improvement(greater than 6 mo), and level Ⅲ evidence for lumbosacral zygapophysial joint injections for short-term improvement only.CONCLUSION: This review provides significant evidence for the diagnostic validity of facet joint nerve blocks, and moderate evidence for therapeutic radiofrequency neurotomy and therapeutic facet joint nerve blocks in managing chronic low back pain.
